Filing Details
- Accession Number:
- 0001179110-17-011244
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-08 19:26:01
- Reporting Period:
- 2017-08-07
- Filing Date:
- 2017-08-08
- Accepted Time:
- 2017-08-08 19:26:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1551152 | Abbvie Inc. | ABBV | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1239127 | A Richard Gonzalez | 1 N. Waukegan Road North Chicago IL 60064 | Chairman Of The Board And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 Par Value | Acquisiton | 2017-08-07 | 193,131 | $51.42 | 469,623 | No | 4 | M | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2017-08-07 | 6,779 | $71.01 | 462,844 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2017-08-07 | 1,809 | $71.03 | 461,035 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2017-08-07 | 100 | $71.06 | 460,935 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2017-08-07 | 3 | $71.07 | 460,932 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2017-08-07 | 6,200 | $71.05 | 454,732 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2017-08-07 | 1,153 | $71.02 | 453,579 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2017-08-07 | 1,800 | $71.06 | 451,779 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2017-08-07 | 157,163 | $71.00 | 294,616 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2017-08-07 | 1,100 | $71.05 | 293,516 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2017-08-07 | 2,602 | $71.04 | 290,914 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2017-08-07 | 3,158 | $71.02 | 287,756 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2017-08-07 | 446 | $71.04 | 287,310 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2017-08-07 | 9,618 | $71.01 | 277,692 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2017-08-07 | 1,200 | $71.03 | 276,492 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (right to buy) | Disposition | 2017-08-07 | 193,131 | $0.00 | 193,131 | $51.42 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-02-20 | 2024-02-19 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, $0.01 Par Value | 4,600 | Indirect | By spouse |
| Common Stock, $0.01 Par Value | 450 | Indirect | By step-daughter |
| Common Stock, $0.01 Par Value | 450 | Indirect | By step-son |
Footnotes
- The reporting person disclaims beneficial ownership of these securities.
- Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.
Billionaire Hedge Funds
